JP2015030689A5 - - Google Patents

Download PDF

Info

Publication number
JP2015030689A5
JP2015030689A5 JP2013160093A JP2013160093A JP2015030689A5 JP 2015030689 A5 JP2015030689 A5 JP 2015030689A5 JP 2013160093 A JP2013160093 A JP 2013160093A JP 2013160093 A JP2013160093 A JP 2013160093A JP 2015030689 A5 JP2015030689 A5 JP 2015030689A5
Authority
JP
Japan
Prior art keywords
resorcinol
external preparation
skin
total amount
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013160093A
Other languages
English (en)
Japanese (ja)
Other versions
JP6212320B2 (ja
JP2015030689A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013160093A priority Critical patent/JP6212320B2/ja
Priority claimed from JP2013160093A external-priority patent/JP6212320B2/ja
Publication of JP2015030689A publication Critical patent/JP2015030689A/ja
Publication of JP2015030689A5 publication Critical patent/JP2015030689A5/ja
Application granted granted Critical
Publication of JP6212320B2 publication Critical patent/JP6212320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013160093A 2013-08-01 2013-08-01 皮膚外用剤 Active JP6212320B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013160093A JP6212320B2 (ja) 2013-08-01 2013-08-01 皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013160093A JP6212320B2 (ja) 2013-08-01 2013-08-01 皮膚外用剤

Publications (3)

Publication Number Publication Date
JP2015030689A JP2015030689A (ja) 2015-02-16
JP2015030689A5 true JP2015030689A5 (enExample) 2016-09-08
JP6212320B2 JP6212320B2 (ja) 2017-10-11

Family

ID=52516319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013160093A Active JP6212320B2 (ja) 2013-08-01 2013-08-01 皮膚外用剤

Country Status (1)

Country Link
JP (1) JP6212320B2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108472203A (zh) * 2015-11-30 2018-08-31 荷兰联合利华有限公司 美容面膜
PH12019501354B1 (en) 2016-12-21 2023-04-19 Unilever Ip Holdings B V Personal care compositions with cystine
CN115444780B (zh) * 2016-12-21 2024-10-15 联合利华知识产权控股有限公司 具有包含烟酰胺和氨基酸的谷胱甘肽前体的个人护理组合物
CA3047495A1 (en) 2016-12-21 2018-06-28 Unilever Plc Topical skin lightening additive and composition with amino acids and nicotinamide compounds
EP3558243B1 (en) 2016-12-21 2022-10-05 Unilever IP Holdings B.V. Personal care compositions comprising poorly soluble compounds
WO2018113634A1 (en) 2016-12-21 2018-06-28 Unilever Plc Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
US11540984B2 (en) 2018-05-23 2023-01-03 Conopco, Inc. Nanoemulsions and a method for making the same
JP7667078B2 (ja) * 2019-06-25 2025-04-22 ロート製薬株式会社 アスコルビン酸及び/又はその塩を含有する外用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
KR960006859B1 (ko) * 1992-03-06 1996-05-23 주식회사 태평양 티로시나제 저해 활성을 갖는 약물의 안정성을 개선하는 방법
JP2000178134A (ja) * 1998-12-16 2000-06-27 Kanae Kagawa:Kk 美白用化粧用剤及びその製造方法
JP2009242321A (ja) * 2008-03-31 2009-10-22 Shiseido Co Ltd 皮膚外用剤
JP2010189368A (ja) * 2009-02-18 2010-09-02 Hiroyuki Iwasaki 液状皮膚外用剤
JP4646269B2 (ja) * 2009-03-31 2011-03-09 株式会社資生堂 皮膚外用剤

Similar Documents

Publication Publication Date Title
JP2015030689A5 (enExample)
JP2015078230A5 (enExample)
WO2014205451A3 (en) Compositions and methods for modulation of target nucleic acids
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
RU2016124331A (ru) Композиция для ухода за полостью рта
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
JP2014218522A5 (enExample)
JP2014515597A5 (enExample)
RU2010154144A (ru) Наружное средство для кожи
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
RU2017133244A (ru) Композиции, содержащие комбинации органических кислот
JP2015500014A5 (enExample)
JP2012533614A5 (enExample)
EA201500821A1 (ru) Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов
JP2014525971A5 (enExample)
EA201791670A1 (ru) Твердые композиции для ухода за полостью рта
EA201590041A1 (ru) Твердая форма холиновой соли вемурафениба
JP2012526881A5 (enExample)
RU2016124158A (ru) Композиция для ухода за полостью рта, содержащая серин и по меньшей мере соль цинка
MX2016001095A (es) Sales de dasatinib en forma cristalina.
JP2013253067A5 (enExample)
JP2012214508A5 (enExample)
JP2015157874A5 (enExample)
FR2999086B1 (fr) Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation
JP2015515877A5 (enExample)